Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...

These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...

Genetic engineering deployed to insert gene for human insulin into a bacterium, thus harnessing the substance for widespread ...

Modular Medical develops patented insulin delivery technologies, aiming to improve access to glycemic control. Its founder, ...

Altitude changes during commercial flights may affect the blood glucose levels of people with type 1 diabetes who are treated with insulin pump therapy, according to new research to be presented ...

Medicare Part B will cover insulin pumps and insulin if a person meets the necessary criteria. Part D will cover prescription insulin and related medical supplies for diabetes. Under Medicare Part ...

Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies ...